Baird Downgrades Sarepta Therapeutics To Neutral
October 28, 2014 at 07:54 AM EDT
Analysts at Baird downgraded Sarepta Therapeutics (NASDAQ: SRPT) from Outperform to Neutral. The price target for Sarepta ...
Baird Downgrades Sarepta Therapeutics To NeutralOctober 28, 2014 at 07:54 AM EDT
Analysts at Baird downgraded Sarepta Therapeutics (NASDAQ: SRPT) from Outperform to Neutral. The price target for Sarepta ...
Related Stocks:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|